NCT07353645 — The Affiliated Nanjing Drum Tower Hospital… neoantigen vaccine trial
KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Registry record
| Registry ID | NCT07353645 ↗ |
|---|---|
| Lead sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
| Collaborators | — |
| Phase | Phase 1/2 |
| Status | Recruiting |
| Indication | Colorectal Cancer, Pancreatic Cancer |
| Enrollment | 49 participants (target) |
| Start date | 2026-03-23 |
| Primary completion | 2029-01-01 (est.) |
| Last registry update | 15 Apr 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT07353645), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT07353645?
NCT07353645 (KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer) is registered on ClinicalTrials.gov as Phase 1/2, sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School.
Is NCT07353645 recruiting?
As of the 2026-04-15 registry update, NCT07353645 is listed as "Recruiting". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT07353645?
The lead sponsor is The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School.
What condition does NCT07353645 study?
The registered conditions are Colorectal Cancer, Pancreatic Cancer. Primary completion is listed as 2029-01-01 (estimated).
Are results available for NCT07353645?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT07353645.
Back to the full neoantigen vaccine trial tracker — 107 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.